GENE ONLINE|News &
Opinion
Blog

Beta-thalassemia
Trials & Approvals CRISPR Genome Editing
Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval
2024-01-18
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Special ASH
64th ASH Annual Meeting and Exposition: Discoveries That Reinvent Blood Disease Treatments
2022-12-20
Trials & Approvals bluebird bio
Bluebird Bio’s Zynteglo Becomes First FDA-Approved Gene Therapy For Beta-Thalassemia
2022-08-18
Trials & Approvals CRISPR
CRISPR Biotech Editas Obtains FDA Rare Pediatric Disease Label
2022-04-27
Trials & Approvals Gene Therapy
FDA Grants Priority Review for bluebird bio’s β-Thalassemia Gene Therapy
2021-11-23
Technology CRISPR
Vertex to Reap Majority Profits from Gene Editing Deal with CRISPR Therapeutics
2021-04-21
Ranking & Reports COVID-19
GeneOnline’s Top 10 Headlines of the Year
2020-12-30
Technology
CRISPR Gene-Edited Therapy CTX001 Raises Hopes for Sickle Cell Disease and β-Thalassemia Cures
2020-12-07
In-Depth Cas9
CRISPR/Cas9 Gene Editing in Cell and Gene Therapies
2020-11-08
Trials & Approvals CRISPR
CRISPR, Vertex’s Gene Editing Based Therapy, CTX001 Prospers in Hemoglobinopathy Trials
2020-06-18
Trials & Approvals Beta-thalassemia
Celgene, Acceleron’s novel anemia drug gets FDA green light for rare blood disorder
2019-11-11
LATEST
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
AI, Smart Tech, and ICT to Unite the Global Biotech and Healthcare Industries in 2025
2024-12-06
Core8 Group to Establish Vietnam’s First Comprehensive Biotechnology Incubator
2024-12-05
Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area
2024-12-05
Ipsen Bets $600M on Biomunex’s First-in-Class T-Cell Engager BMX-502
2024-12-03
Gilead Strikes Again: $415M Bet on ADCs with Tubulis Deal
2024-12-03
FDA Investigates Reports of Blood Cancer Cases Linked to Gene Therapy
2024-12-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top